Abiopharma

New Form 8-K - Foghorn Therapeutics Inc. Filed: 2025-07-01 AccNo: 0001628280-25-033784 Size: 23 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits